This invention describes resins with phosphate cores and a simple, three-step process for their synthesis. Preferred resins are cyanate ester resins with bridging phosphate groups. These resins can be cured to produce thermoset polymers having T.sub.gs of between 131 and >360 C. depending on the number of cyanate ester groups per phosphate and the substitution pattern of the aromatic rings. The high char yields of these resins, up to about 67%, coupled with the phosphate core means that these materials will have applications as fire-resistant polymers. Additionally, these materials can potentially be blended with conventional cyanate esters or other compatible thermosetting resins to improve the fire resistance of composite materials. Other applications may include use in fire-resistant circuit boards, or as surface coatings to reduce flammability of conventional composite materials or thermoplastics.

This invention describes resins with phosphate cores and a simple, three-step process for their synthesis. Preferred resins are cyanate ester resins with bridging phosphate groups. These resins can be cured to produce thermoset polymers having T.sub.gs of between 131 and >360 C. depending on the number of cyanate ester groups per phosphate and the substitution pattern of the aromatic rings. The high char yields of these resins, up to about 67%, coupled with the phosphate core means that these materials will have applications as fire-resistant polymers. Additionally, these materials can potentially be blended with conventional cyanate esters or other compatible thermosetting resins to improve the fire resistance of composite materials. Other applications may include use in fire-resistant circuit boards, or as surface coatings to reduce flammability of conventional composite materials or thermoplastics.

The invention concerns a phosphoric acid ester of Formula (I) or (II), wherein: A, B and R represents an aliphatic, cycloaliphatic and/ or aromatic moiety; Q represents CH.sub.2, O or COO; n+m is inferior to 3; and X+Y is less than 7, and wherein the phosphoric acid ester has an average molecular weight M.sub.n of 70 to 10,000 g/mol. The invention also concern the process for making the phosphoric acid ester of Formula (I) or (II), and there us as dispersants of particles in a liquid medium, such as water, solvent, plasticizer or resin. Advantageously, the process allows the preparation of new high performing polymeric phosphate esters with less acidic character that are majorly a phosphate diester. Also, a 100% active liquid solvent free polyester phosphate ester can be effectively prepared.

##STR00001##

The invention concerns a phosphoric acid ester of Formula (I) or (II), wherein: A, B and R represents an aliphatic, cycloaliphatic and/ or aromatic moiety; Q represents CH.sub.2, O or COO; n+m is inferior to 3; and X+Y is less than 7, and wherein the phosphoric acid ester has an average molecular weight M.sub.n of 70 to 10,000 g/mol. The invention also concern the process for making the phosphoric acid ester of Formula (I) or (II), and there us as dispersants of particles in a liquid medium, such as water, solvent, plasticizer or resin. Advantageously, the process allows the preparation of new high performing polymeric phosphate esters with less acidic character that are majorly a phosphate diester. Also, a 100% active liquid solvent free polyester phosphate ester can be effectively prepared.

##STR00001##

Self-assembled monolayers (SAMs) were selectively prepared on portions of a substrate surface utilizing compounds comprising a hydrogen-bonding group and polymerizable diacetylene group. The SAMs were photopolymerized using ultraviolet light. The pre-polymerized and polymerized SAMs were more effective barriers against metal deposition in an atomic layer deposition process compared to similar compounds lacking these functional groups.

Self-assembled monolayers (SAMs) were selectively prepared on portions of a substrate surface utilizing compounds comprising a hydrogen-bonding group and polymerizable diacetylene group. The SAMs were photopolymerized using ultraviolet light. The pre-polymerized and polymerized SAMs were more effective barriers against metal deposition in an atomic layer deposition process compared to similar compounds lacking these functional groups.

The present invention provides new classes of phenolic compounds derived from hydroxyacids and tyrosol or tyrosol analogues, useful as monomers for preparation of biocompatible polymers, and the biocompatible polymers prepared from these monomeric hydroxyacid-phenolic compounds, including novel biodegradable and/or bioresorbable polymers. These biocompatible polymers or polymer compositions with enhanced bioresorbabilty and processability are useful in a variety of medical applications, such as in medical devices and controlled-release therapeutic formulations. The invention also provides methods for preparing these monomeric hydroxyacid-phenolic compounds and biocompatible polymers.

Disclosed are a fluorine-silicon-containing polyphosphate ester and method for preparation thereof, having a chemical structural formula of:

##STR00001##

wherein R .sub.1 is

##STR00002##

R .sub.2 is

##STR00003##

n=10100. The fluorine-silicon-containing polyphosphate ester of the present invention uses silicon phosphorus and fluorine for improving flame retardancy. Phosphorus catalyzes the system to form a phosphorus-rich carbon layer, performing a protective-layer function and thereby preventing further breakdown of the epoxy resin. The silicon-containing epoxy resin forms a silica-containing carbon layer during the process of combustion, strengthening the carbon-layer structure and further improving the protective function of the carbon-layer. The introduction of elemental fluorine improves the thermal stability of the epoxy resin, thereby improving the flame retardancy performance of the system.

Methods of providing a stent assembly that includes a stent jacket formed from an expansible mesh structure having apertures and that includes a fiber having a diameter of about 7 micrometers and about 40 micrometers, and an expansible stent operatively associated with the stent jacket. The method further comprises administering to the subject an active pharmaceutical ingredient (API) eluted from the stent assembly.

Methods of providing a stent assembly that includes a stent jacket formed from an expansible mesh structure having apertures and that includes a fiber having a diameter of about 7 micrometers and about 40 micrometers, and an expansible stent operatively associated with the stent jacket. The method further comprises administering to the subject an active pharmaceutical ingredient (API) eluted from the stent assembly.